![Jennifer Mendoza](https://cdn.statcdn.com/static/../CMS/contactperson/ERI2166_1721301667.jpg)
Latin America: gastroparesis drugs market value 2020-2025
By 2025, the forecasted value of the gastroparesis drugs market in Latin America its estimated to reach 810 million U.S. dollars, an increase of nearly 30 percent from 630 million U.S. dollars in 2020. Gastroparesis drugs are used to calm the side-affects of gastroparesis, such as vomiting and indigestion. These drugs have become more prevalent as stomach related illnesses have increased across Latin America.